Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2018-09-24 2017-09-19
Drug Identification Number 02212366 02212366
Brand name ZANTAC ZANTAC
Common or Proper name Ranitidine injection Ranitidine injection
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients RANITIDINE RANITIDINE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size All pack sizes / Tous les formats All pack sizes / Tous les formats
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-08-31
Actual discontinuation date 2018-08-31
Remaining supply date 2018-11-14 2018-11-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments